Ocular Therapeutix, Inc.

OCUL · Healthcare

$10.57

Capitalización: 2.32B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Ocular Therapeutix, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

Insider Monkey3 sept 2026, 11:06

Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs

GlobeNewswire1 sept 2026, 11:00

Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences

StockStory1 sept 2026, 10:10

1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges

Simply Wall St.22 ago 2026, 6:10

Ocular Therapeutix (OCUL) Could Be 59% Undervalued Following Earnings Beat And AXPAXLI Progress

StockStory21 ago 2026, 19:47

Pharmaceuticals Stocks Q2 Highlights: Ocular Therapeutix (NASDAQ:OCUL)